Resolution of paraneoplastic immune thrombocytopenia following everolimus treatment for metastatic renal cell carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|45|6|666-669

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.45, Iss.6, 2015-06, pp. : 666-669

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Severe Thrombocytopenia in a Patient with Metastatic Renal Cell Carcinoma

By  

Oncology Research and Treatment, Vol. 32, Iss. 11, 2009-10 ,pp. : 670-672

Karger

Access to resources Recommend Favorite

Comparative outcomes of everolimus, temsirolimus and sorafenib as second targeted therapies for metastatic renal cell carcinoma: a US medical record review

By Wong Michael K.   Yang Hongbo   Signorovitch James E.   Wang Xufang   Liu Zhimei   Liu Nathan S.   Qi Cynthia Z.   George Daniel J.  

Current Medical Research and Opinion, Vol. 30, Iss. 4, 2014-04 ,pp. : 537-545

Informa Healthcare

Access to resources Recommend Favorite

Kaposi's Varicelliform-Like Eruption in a Patient Treated with Everolimus for Metastatic Renal Cell Carcinoma: Report of a Rare Case

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-05 ,pp. : 337-342

Karger

Access to resources Recommend Favorite

An Unusual Metastatic Renal Cell Carcinoma with Maintained Complete Response to Sunitinib Treatment

By  

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-12 ,pp. : 583-586

Karger

Access to resources Recommend Favorite

Mature Dendritic Cells Induce T-Helper Type-1-Dominant Immune Responses in Patients with Metastatic Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 63, Iss. 3, 2000-01 ,pp. : 151-159

Karger

Access to resources Recommend Favorite